H7N9 Live attenuated influenza vaccine is highly immunogenic, prevents virus replication and protects against severe bronchopneumonia in ferrets

enthalten in: Molecular therapy | 2016

von de Jonge, J. | Spijkers, S. | Smolonogina, T. | +6

H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial

enthalten in: The lancet / Infectious diseases | 2016

von Rudenko, L. | Isakova-Sivak, I. | Naykhin, A. | +7

H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets

enthalten in: Molecular therapy | 2016

von de Jonge, J. | Isakova-Sivak, I. | van Dijken, H. | +6

Reassortant viruses for influenza vaccines: is it time to reconsider their genome structures?

enthalten in: Expert review of vaccines | 2016

von Isakova-Sivak, I. | Korenkov, D. | Rudenko, L.

Cold-adapted influenza viruses as a promising platform for viral-vector vaccines

enthalten in: Expert review of vaccines | 2016

von Isakova-Sivak, I. | Tretiak, T. | Rudenko, L.

Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories

enthalten in: Vaccine | 2016

von Rudenko, L. | Yeolekar, L. | Kiseleva, I. | +1

Cold-adapted influenza viruses as a promising platform for viral-vector vaccines

enthalten in: Expert review of vaccines | 2016

von Isakova-Sivak, I. | Tretiak, T. | Rudenko, L.

Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories

enthalten in: Vaccine | 2016

von Rudenko, L. | Yeolekar, L. | Kiseleva, I. | +1